The present invention provides antibody drug conjugates, wherein an antibody or antibody fragment that specifically binds to human cKIT is linked to a drug moiety, optionally through a linker. The present invention further provides pharmaceutical compositions comprising the antibody drug conjugates； and methods of making and using such pharmaceutical compositions for ablating hematopoietic stem cells in a patient in need thereof.
